Ilana Golub

Dr. Ilana Golub

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Atherosclerosis
Verified
Journal Article
Closed access
IGIlana Golub
Ilana Golub
SLSuvasini Lakshmanan
Suvasini Lakshmanan
SDSuraj Dahal
Suraj Dahal
Matthew Jay BudoffMatthew Jay Budoff
Matthew Jay Budoff

19 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IGIlana Golub
Ilana Golub
ATAbhinav Thummala
Abhinav Thummala
TMTyler Morad
Tyler Morad
JDJasmeet S. Dhaliwal
Jasmeet S. Dhaliwal
FEFrancisco Xavier Elisarraras
Francisco Xavier Elisarraras
GCGeoffrey Weiting Cho
Geoffrey Weiting Cho
Cardiovascular disease (CVD) is a leading cause of death, accounting for over 30% of annual global fatalities. Ischemic heart disease, in turn, is a frontrunner of worldwide CVD mortality. With the burden of coronary disease rapidly growing, understanding the nuances of cardiac imaging and risk prognostication becomes paramount. Myocardial perfusion imaging (MPI) is a frequently utilized and well established testing modality due to its significant clinical impact in disease diagnosis and risk assessment. Recently, nuclear cardiology has witnessed major advancements, driven by innovations in novel imaging technologies and improved understanding of cardiovascular pathophysiology. Applications of artificial intelligence (AI) to MPI have enhanced diagnostic accuracy, risk stratification, and therapeutic decision-making in patients with coronary artery disease (CAD). AI techniques such as machine learning (ML) and deep learning (DL) neural networks offer new interpretations of immense data fields, acquired through cardiovascular imaging modalities such as nuclear medicine (NM). Recently, AI algorithms have been employed to enhance image reconstruction, reduce noise, and assist in the interpretation of complex datasets. The rise of AI in nuclear medicine (AI-NM) has proven itself groundbreaking in the efficiency of image acquisition, post-processing time, diagnostic ability, consistency, and even in risk-stratification and outcome prognostication. To that end, this narrative review will explore these latest advances in AI in nuclear medicine and its rapid transformation of the cardiac diagnostics landscape. This paper will examine the evolution of AI-NM, review novel AI techniques and applications in nuclear cardiac imaging, summarize recent AI-NM clinical trials, and explore the technical and clinical challenges in its implementation of artificial intelligence.

7 April 2025 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
IGIlana Golub
Ilana Golub
VMVenkat S. Manubolu
Venkat S. Manubolu
JAJairo Aldana-Bitar
Jairo Aldana-Bitar
SDSuraj Dahal
Suraj Dahal
DVDhiran Verghese
Dhiran Verghese
Matthew Jay BudoffMatthew Jay Budoff
Matthew Jay Budoff

4 March 2022
Verified
Book Chapter
Closed access
PDF file
VDVita Droutman
Vita Droutman
Peizhong WangPeizhong Wang
Peizhong Wang
IGIlana Golub
Ilana Golub
SRStephen Read
Stephen Read

1 July 2020 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
VRV. Rezvanizadeh
V. Rezvanizadeh
NNN. Nezarat
N. Nezarat
SDS. Dahal
S. Dahal
SLS. Lakshmanan
S. Lakshmanan
ACA. Cai
A. Cai
Matthew Jay BudoffMatthew Jay Budoff
Matthew Jay Budoff

1 July 2020 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
DBD. Birudaraju
D. Birudaraju
SLS. Lakhshmanan
S. Lakhshmanan
HMH. Mateusz
H. Mateusz
AKApril Kinninger
April Kinninger
LCL. Cherukuri
L. Cherukuri
Matthew Jay BudoffMatthew Jay Budoff
Matthew Jay Budoff